SUPERNUS PHARMACEUTICALS INC USD0.001 earnings per share and revenue

0LB2 earnings per share for the last quarter are 0.75 USD whereas the estimation was 0.52 USD which accounts for 43.54% surprise. Company revenue for the same period amounts to 174.16 M USD despite the estimated figure of 155.25 M USD. Estimated earnings per share for the next quarter are 0.41 USD, and revenue is expected to reach 144.20 M USD. Also watch annual changes over time to get a bigger picture of 0LB2 earnings per share and revenue dynamics.